Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02654132 |
|---|---|
| Brief Title: | An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) |
| First Submitted : | December 31, 2015 |
| First Submitted that Met QC Criteria : | January 12, 2016 |
| First Posted : | January 13, 2016 (Estimate) |
| Results First Submitted : | January 17, 2019 |
| Results First Submitted that Met QC Criteria : | May 31, 2019 |
| Results First Posted : | June 3, 2019 |
| Last Update Submitted that Met QC Criteria : | October 5, 2022 |
| Last Update Posted : | November 1, 2022 |